Crestor
Product Images NDC 69189-0752

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Crestor (NDC 69189-0752). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avera Mckennan Hospital, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Strucural Formula (3a498c46 5ad2 416a 875e 18e48b586954 01)

Chemical structure diagram of the active ingredient in CRESTOR, showing its molecular formula with various functional groups, including fluorine, hydroxyl groups, and a calcium ion (Ca2+) complex.*

FDA Label Image

Figure One (3a498c46 5ad2 416a 875e 18e48b586954 02)

A box-and-whisker plot comparing the percent change from baseline in LDL-C levels for different doses of CRESTOR (rosuvastatin), Atorvastatin, Simvastatin, and Pravastatin. The x-axis lists the statin types and their respective dose ranges in milligrams, while the y-axis shows percent change from -75 to -15. The plot visualizes LDL-C reduction variability across various statin doses.*

FDA Label Image

Figure Two (3a498c46 5ad2 416a 875e 18e48b586954 03)

A Kaplan-Meier plot showing cumulative incidence percentage over years, comparing two groups: Placebo (dotted line) and Rosuva (solid line). The chart includes hazard ratio (HR 0.56, 95% CI 0.46-0.69) and p-value (P<0.001). Below the graph, the number at risk for RSV and Placebo groups are displayed at multiple time points up to 5 years.*

FDA Label Image

Figure Three (3a498c46 5ad2 416a 875e 18e48b586954 04)

A data table presenting the number of events, hazard ratios with 95% confidence intervals, and p-values comparing Rosuva 20 mg and placebo 20 mg groups for various cardiovascular endpoints, including primary endpoint, cardiovascular death, stroke, myocardial infarction, unstable angina hospitalizations, and arterial revascularization, alongside a hazard ratio plot.*

FDA Label Image

Rosuvastatin Calcium 20 mg Tablet (6918907521)

Label of CRESTOR 20 mg tablet containing rosuvastatin calcium. The label indicates manufacturing by AstraZeneca with a lot number, hospital lot number, and expiration date of 04/13/2017. The label also includes the product NDC 69189-0752 and notes the labeler as Avera McKennan in Sioux Falls, SD.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.